Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-09 Schlanger David J Executive Chairman Sale 10b5-1 −19,490 $38.25 $745K 73,487
2023-05-09 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −100,000 516,821
2023-05-09 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion 10b5-1 +32,000 $3.95 $126K 247,924
2023-05-09 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −1,348 $36.76 $50K 246,576
2023-05-09 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −24,382 $37.61 $917K 222,194
2023-05-09 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −6,270 $38.24 $240K 215,924
2023-05-09 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −337 $36.76 $12K 77,413
2023-05-09 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −6,095 $37.61 $229K 65,223
2023-05-09 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −1,568 $38.24 $60K 63,655
2023-05-09 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −32,000 1,008,164
2023-05-08 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +67,887 $0.91 $62K 141,374
2023-05-08 Schlanger David J Executive Chairman Sale 10b5-1 −67,887 $35.11 $2.4M 73,487
2023-05-08 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −67,887 616,821
2023-05-08 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion 10b5-1 +22,932 $3.95 $91K 238,856
2023-05-08 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −22,932 $35.09 $805K 215,924
2023-05-08 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −5,733 $35.09 $201K 77,750
2023-05-08 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −22,932 1,040,164
2023-04-25 Livingston Mark S. CHIEF FINANCIAL OFFICER Shares withheld for taxes −226 $34.52 $8K 63,181
2023-04-24 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion 10b5-1 +1,857 $3.95 $7K 217,781
2023-04-24 Anevski Peter CHIEF EXECUTIVE OFFICER Sale 10b5-1 −1,857 $35.00 $65K 215,924

Page 26 of 77 · 1,524 trades